Innovent Biologics, Inc. (INNOVENT) balance sheet

HKSE · Healthcare · Biotechnology · 8,754 employees · CEO De-Chao Yu

Price: HK$80.65 +1.13%
Market cap: HK$141B
Enterprise value: CN¥104B
Last report: Q2 '26 filed 2026-06-30
Next report: 2027-03-31

At the end of Q2 '26 Innovent Biologics, Inc. (INNOVENT) held CN¥20B in cash and short-term investments against CN¥2.32B of debt incl. leases. Total assets CN¥41.6B, total liabilities CN¥20.9B, shareholders' equity CN¥20.7B.

Balance sheet

Balance sheet	Q4 '20	Q2 '21	Q4 '21	Q2 '22	Q4 '22	Q2 '23	Q4 '23	Q2 '24	Q4 '24	Q2 '25	Q4 '25	Q2 '26
Assets
Cash & equivalents	CN¥1.28B	CN¥4.46B	CN¥1.36B	CN¥1.35B	CN¥1.02B	CN¥1.33B	CN¥10.1B	CN¥8.17B	CN¥7.51B	CN¥9.54B	CN¥17.4B	CN¥17.4B
Short-term investments	CN¥6.77B	CN¥6.22B	CN¥6.58B	CN¥5.68B	CN¥7.25B	CN¥6.32B	CN¥868M	CN¥463M	CN¥376M	CN¥0	CN¥887M	CN¥2.62B
Receivables	CN¥640M	CN¥1.17B	CN¥1.18B	CN¥1.4B	CN¥912M	CN¥1.56B	CN¥1.01B	CN¥1.37B	CN¥1.57B	CN¥1.72B	CN¥1.75B	CN¥1.9B
Inventory	CN¥706M	CN¥1.1B	CN¥1.35B	CN¥1.48B	CN¥1.43B	CN¥1.3B	CN¥968M	CN¥690M	CN¥822M	CN¥1.13B	CN¥1.3B	CN¥1.88B
Other current assets	CN¥548M	CN¥1.48B	CN¥975M	CN¥2.47B	CN¥1.81B	CN¥2.43B	CN¥484M	CN¥361M	CN¥0	CN¥702M	CN¥729M	CN¥1.21B
Current assets	CN¥9.47B	CN¥13.4B	CN¥11.6B	CN¥11.2B	CN¥11.5B	CN¥11.4B	CN¥13.4B	CN¥11B	CN¥10.3B	CN¥13.1B	CN¥22B	CN¥25B
Property, plant & equipment (net)	CN¥2.18B	CN¥2.72B	CN¥3.38B	CN¥3.61B	CN¥4.06B	CN¥4.45B	CN¥4.66B	CN¥5.42B	CN¥5.65B	CN¥5.6B	CN¥5.44B	CN¥5.33B
Long-term investments	-CN¥6.76B	-CN¥6.17B	CN¥512M	CN¥465M	CN¥713M	-CN¥5.68B	CN¥794M	CN¥2.3B	CN¥3.9B	CN¥3.13B	CN¥7.89B	CN¥8.89B
Intangible assets	CN¥32.6M	CN¥96.9M	CN¥772M	CN¥816M	CN¥1.2B	CN¥1.19B	CN¥27.8M	CN¥987M	CN¥1.28B	CN¥1.39B	CN¥1.53B	CN¥1.47B
Deferred tax assets	CN¥0	CN¥0	CN¥4.36B	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥472M
Other non-current assets	CN¥6.91B	CN¥6.38B	-CN¥4.33B	CN¥78.2M	CN¥110M	CN¥6.55B	CN¥1.72B	CN¥537M	CN¥499M	CN¥379M	CN¥471M	CN¥461M
Non-current assets	CN¥2.37B	CN¥3.02B	CN¥4.69B	CN¥4.96B	CN¥6.08B	CN¥6.51B	CN¥7.2B	CN¥9.25B	CN¥11.3B	CN¥10.5B	CN¥15.3B	CN¥16.6B
Total assets	CN¥11.8B	CN¥16.5B	CN¥16.2B	CN¥16.2B	CN¥17.6B	CN¥17.9B	CN¥20.6B	CN¥20.3B	CN¥21.6B	CN¥23.6B	CN¥37.4B	CN¥41.6B
Liabilities
Accounts payable	CN¥121M	CN¥277M	CN¥195M	CN¥236M	CN¥326M	CN¥216M	CN¥373M	CN¥221M	CN¥358M	CN¥432M	CN¥495M	CN¥931M
Accrued expenses	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥2.07B	CN¥0	CN¥0	CN¥0	CN¥0
Short-term debt	CN¥255M	CN¥370M	CN¥365M	CN¥858M	CN¥888M	CN¥450M	CN¥1.2B	CN¥935M	CN¥405M	CN¥1.11B	CN¥801M	CN¥540M
Taxes payable	CN¥5.69M	CN¥356K	CN¥92.8M	CN¥23.6M	CN¥61M	CN¥67.7M	CN¥194M	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0
Deferred revenue	CN¥0	CN¥0	-CN¥1.03B	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥2.31B	CN¥2.05B
Other current liabilities	CN¥770M	CN¥962M	CN¥1.71B	CN¥1.9B	CN¥1.64B	CN¥1.47B	CN¥2.02B	CN¥830M	CN¥2.32B	CN¥3.47B	CN¥4.77B	CN¥5.21B
Current liabilities	CN¥1.49B	CN¥2.24B	CN¥3.05B	CN¥3.48B	CN¥3.5B	CN¥2.87B	CN¥4.48B	CN¥4.13B	CN¥4.37B	CN¥5.01B	CN¥8.39B	CN¥9.32B
Long-term debt	CN¥925M	CN¥1.47B	CN¥2.02B	CN¥1.81B	CN¥2.22B	CN¥2.89B	CN¥2.33B	CN¥2.27B	CN¥2.41B	CN¥2.26B	CN¥1.99B	CN¥1.76B
Lease obligations (non-current)	CN¥10.2M	CN¥3.13M	CN¥86.4M	CN¥84.2M	CN¥98.7M	CN¥86.7M	CN¥73.4M	CN¥66.3M	CN¥4.76M	CN¥1.61M	CN¥26M	CN¥20.6M
Deferred revenue (non-current)	CN¥634M	CN¥838M	CN¥753M	CN¥1.19B	CN¥883M	CN¥1.03B	CN¥960M	CN¥991M	CN¥1.22B	CN¥1.23B	CN¥6.15B	CN¥9.1B
Deferred tax liabilities	-CN¥634M	-CN¥838M	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0
Other non-current liabilities	CN¥0	CN¥0	CN¥342K	CN¥1.19B	CN¥1.05B	CN¥1.27B	CN¥263M	CN¥1.4B	CN¥1.7B	CN¥1.9B	CN¥643M	CN¥660M
Non-current liabilities	CN¥1.57B	CN¥2.31B	CN¥2.86B	CN¥3.09B	CN¥3.36B	CN¥4.24B	CN¥3.62B	CN¥3.74B	CN¥4.12B	CN¥4.16B	CN¥8.81B	CN¥11.5B
Total liabilities	CN¥3.06B	CN¥4.55B	CN¥5.91B	CN¥6.57B	CN¥6.86B	CN¥7.11B	CN¥8.1B	CN¥7.87B	CN¥8.48B	CN¥9.17B	CN¥17.2B	CN¥20.9B
Equity
Common stock & paid-in capital	CN¥97K	CN¥100K	CN¥101K	CN¥101K	CN¥105K	CN¥106K	CN¥112K	CN¥112K	CN¥113K	CN¥114K	CN¥119K	CN¥120K
Retained earnings	-CN¥9.98B	-CN¥11.2B	-CN¥15.4B	-CN¥15.8B	-CN¥16.7B	-CN¥14.9B	-CN¥15.8B	-CN¥16.2B	-CN¥15.9B	-CN¥15.1B	-CN¥15.1B	-CN¥13.8B
Accumulated other comprehensive income	CN¥220M	CN¥595M	CN¥397M	CN¥558M	CN¥764M	CN¥762M	CN¥971M	CN¥1.04B	CN¥1.3B	CN¥14.4B	CN¥1.55B	CN¥1.2B
Shareholders' equity	CN¥8.78B	CN¥11.9B	CN¥10.3B	CN¥9.59B	CN¥10.7B	CN¥10.8B	CN¥12.5B	CN¥12.4B	CN¥13.1B	CN¥14.4B	CN¥19.4B	CN¥20.7B
Debt
Total debt (incl. leases)	CN¥1.21B	CN¥1.86B	CN¥2.5B	CN¥2.77B	CN¥3.23B	CN¥3.45B	CN¥3.62B	CN¥3.35B	CN¥2.83B	CN¥3.38B	CN¥2.82B	CN¥2.32B
Net debt (debt - cash)	-CN¥69.6M	-CN¥2.61B	CN¥1.14B	CN¥1.41B	CN¥2.21B	CN¥2.12B	-CN¥6.43B	-CN¥4.82B	-CN¥4.68B	-CN¥6.16B	-CN¥14.5B	-CN¥15.1B

Balance sheet	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Assets
Cash & equivalents	CN¥1.01B	CN¥510M	CN¥4.53B	CN¥2.43B	CN¥1.28B	CN¥1.36B	CN¥1.02B	CN¥10.1B	CN¥7.51B	CN¥17.4B
Short-term investments	CN¥782M	CN¥809M	CN¥0	CN¥2.27B	CN¥6.77B	CN¥6.58B	CN¥7.25B	CN¥868M	CN¥376M	CN¥887M
Receivables	CN¥0	CN¥0	CN¥7.51M	CN¥250M	CN¥640M	CN¥1.18B	CN¥912M	CN¥1.01B	CN¥1.57B	CN¥1.75B
Inventory	CN¥36.6M	CN¥57.7M	CN¥66.1M	CN¥359M	CN¥706M	CN¥1.35B	CN¥1.43B	CN¥968M	CN¥822M	CN¥1.3B
Other current assets	CN¥38.9M	CN¥68.1M	CN¥15M	CN¥152M	CN¥0	CN¥6.64M	CN¥901M	CN¥484M	CN¥0	CN¥729M
Current assets	CN¥1.87B	CN¥1.45B	CN¥4.69B	CN¥5.46B	CN¥9.47B	CN¥11.6B	CN¥11.5B	CN¥13.4B	CN¥10.3B	CN¥22B
Property, plant & equipment (net)	CN¥789M	CN¥822M	CN¥1.12B	CN¥1.52B	CN¥2.18B	CN¥3.38B	CN¥4.06B	CN¥4.66B	CN¥5.65B	CN¥5.44B
Long-term investments	CN¥0	CN¥0	CN¥0	-CN¥2.27B	-CN¥6.76B	-CN¥6.16B	CN¥630M	CN¥794M	CN¥3.9B	CN¥7.89B
Intangible assets	CN¥55.3M	CN¥54.1M	CN¥52.8M	CN¥0	CN¥32.6M	CN¥772M	CN¥1.2B	CN¥27.8M	CN¥1.28B	CN¥1.53B
Other non-current assets	CN¥101M	CN¥136M	CN¥250M	CN¥2.52B	CN¥6.91B	CN¥6.71B	CN¥193M	CN¥1.72B	CN¥499M	CN¥471M
Non-current assets	CN¥945M	CN¥1.01B	CN¥1.43B	CN¥1.78B	CN¥2.37B	CN¥4.69B	CN¥6.08B	CN¥7.2B	CN¥11.3B	CN¥15.3B
Total assets	CN¥2.82B	CN¥2.46B	CN¥6.11B	CN¥7.23B	CN¥11.8B	CN¥16.2B	CN¥17.6B	CN¥20.6B	CN¥21.6B	CN¥37.4B
Liabilities
Accounts payable	CN¥21.2M	CN¥34.8M	CN¥42.8M	CN¥84.3M	CN¥121M	CN¥195M	CN¥326M	CN¥373M	CN¥358M	CN¥495M
Accrued expenses	CN¥28.6M	CN¥105M	CN¥519M	CN¥782M	CN¥820M	CN¥1.68B	CN¥1.52B	CN¥2.16B	CN¥0	CN¥0
Short-term debt	CN¥0	CN¥5M	CN¥10M	CN¥17M	CN¥255M	CN¥365M	CN¥888M	CN¥1.2B	CN¥405M	CN¥801M
Taxes payable	CN¥2.4M	CN¥1.08M	CN¥1.08M	CN¥1.75M	CN¥5.69M	CN¥92.8M	CN¥61M	CN¥194M	CN¥0	CN¥0
Deferred revenue	CN¥0	-CN¥30.8M	-CN¥96.9M	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥2.31B
Other current liabilities	CN¥26.4M	CN¥18M	CN¥98.4M	CN¥144M	CN¥274M	CN¥790M	CN¥742M	CN¥728M	CN¥2.32B	CN¥4.77B
Current liabilities	CN¥76.2M	CN¥163M	CN¥670M	CN¥1.04B	CN¥1.49B	CN¥3.05B	CN¥3.5B	CN¥4.48B	CN¥4.37B	CN¥8.39B
Long-term debt	CN¥500M	CN¥505M	CN¥782M	CN¥808M	CN¥925M	CN¥2.02B	CN¥2.22B	CN¥2.33B	CN¥2.41B	CN¥1.99B
Lease obligations (non-current)	CN¥0	CN¥0	CN¥0	CN¥24.5M	CN¥10.2M	CN¥86.4M	CN¥98.7M	CN¥73.4M	CN¥4.76M	CN¥26M
Deferred revenue (non-current)	CN¥302M	CN¥360M	CN¥466M	CN¥598M	CN¥634M	CN¥753M	CN¥883M	CN¥960M	CN¥1.22B	CN¥6.15B
Deferred tax liabilities	CN¥2.89B	CN¥3.04B	-CN¥16M	-CN¥16.5M	-CN¥634M	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0
Other non-current liabilities	CN¥312M	CN¥371M	CN¥0	CN¥0	CN¥634M	CN¥342K	CN¥162M	CN¥263M	CN¥1.7B	CN¥643M
Non-current liabilities	CN¥3.7B	CN¥3.92B	CN¥1.25B	CN¥1.43B	CN¥1.57B	CN¥2.86B	CN¥3.36B	CN¥3.62B	CN¥4.12B	CN¥8.81B
Total liabilities	CN¥3.77B	CN¥4.08B	CN¥1.92B	CN¥2.47B	CN¥3.06B	CN¥5.91B	CN¥6.86B	CN¥8.1B	CN¥8.48B	CN¥17.2B
Equity
Common stock & paid-in capital	CN¥6K	CN¥8K	CN¥79K	CN¥87K	CN¥97K	CN¥101K	CN¥105K	CN¥112K	CN¥113K	CN¥119K
Retained earnings	-CN¥1.04B	-CN¥1.79B	-CN¥8.27B	-CN¥8.98B	-CN¥9.98B	-CN¥12.6B	-CN¥14.7B	-CN¥15.8B	-CN¥15.9B	-CN¥15.1B
Accumulated other comprehensive income	-CN¥465M	-CN¥505M	-CN¥293M	-CN¥146M	CN¥220M	CN¥397M	CN¥764M	CN¥971M	CN¥1.3B	CN¥1.55B
Shareholders' equity	-CN¥1.38B	-CN¥1.94B	CN¥4.19B	CN¥4.76B	CN¥8.78B	CN¥10.3B	CN¥10.7B	CN¥12.5B	CN¥13.1B	CN¥19.4B
Debt
Total debt (incl. leases)	CN¥500M	CN¥510M	CN¥792M	CN¥865M	CN¥1.21B	CN¥2.5B	CN¥3.23B	CN¥3.62B	CN¥2.83B	CN¥2.82B
Net debt (debt - cash)	-CN¥513M	-CN¥471K	-CN¥3.73B	-CN¥1.56B	-CN¥69.6M	CN¥1.14B	CN¥2.21B	-CN¥6.43B	-CN¥4.68B	-CN¥14.5B

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in CNY.

Cash, investments and debt

quarter ends

The other statements

Income statementRevenue, costs, operating income, net income and EPSOpen Cash flowOperating cash flow, capex, free cash flow, buybacks and dividendsOpen

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings.

Data as of 2026-11-02 · Amounts in CNY as reported; price and market cap in HKD.